Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer

SIMPLE SUMMARY: Ovarian cancer is the eighth most common cancer among women and has a 5-year survival of only 30–50%. The survival is close to 90% for patients in stage I but only 20% for patients in stage IV. The presently available biomarkers have insufficient sensitivity and specificity for early...

Descripción completa

Detalles Bibliográficos
Autores principales: Gyllensten, Ulf, Hedlund-Lindberg, Julia, Svensson, Johanna, Manninen, Johanna, Öst, Torbjörn, Ramsell, Jon, Åslin, Matilda, Ivansson, Emma, Lomnytska, Marta, Lycke, Maria, Axelsson, Tomas, Liljedahl, Ulrika, Nordlund, Jessica, Edqvist, Per-Henrik, Sjöblom, Tobias, Uhlén, Mathias, Stålberg, Karin, Sundfeldt, Karin, Åberg, Mikael, Enroth, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997113/
https://www.ncbi.nlm.nih.gov/pubmed/35406529
http://dx.doi.org/10.3390/cancers14071757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997113/
https://www.ncbi.nlm.nih.gov/pubmed/35406529
http://dx.doi.org/10.3390/cancers14071757

Ejemplares similares